Picture of Autolus Therapeutics logo

AUTL Autolus Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSucker Stock

Autolus Therapeutics PLC reports results for the quarter ended in December - Earnings Summary

* Autolus Therapeutics PLC  AUTL.OQ  reported a quarterly
adjusted
loss of 45 cents​​ per share for the quarter ended in December,
lower than the same quarter last year, when the company reported
EPS of -23 cents.  The mean expectation of eight analysts for
the quarter was for a loss of 25 cents per share. Wall Street
expected results to range from -29 cents to -20 cents per share.
    * Reported revenue was zero​; analysts expected $358.40
thousand. 
    * Autolus Therapeutics PLC's reported EPS for the quarter
was a
loss of 45 cents​.
    * The company reported a quarterly loss of $77.17 million.
    * Autolus Therapeutics PLC shares had fallen by 14.9% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Autolus
Therapeutics PLC is $10.00 
This summary was machine generated from LSEG data March 14 at
01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.25          -0.45          Missed
 Sep. 30 2023      -0.25          -0.26          Missed
 Jun. 30 2023      -0.22          -0.26          Missed
 Mar. 31 2023      -0.27          -0.23          Beat

Recent news on Autolus Therapeutics

See all news